Maze Therapeutics Announces Pricing of Upsized Initial Public Offering
January 30, 2025 19:30 ET | Source: Maze Therapeutics, Inc. SOUTH SAN…
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease…
BioAge Labs to Present at Upcoming Investor Conferences
November 21, 2024 16:30 ET | Source: BioAge Labs, Inc. RICHMOND, Calif.,…
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 07, 2024 16:30 ET | Source: BioAge Labs, Inc. Initiated Phase…